Project Grant HT94252410813
Award Date 8/1/24
Completion Date 7/31/27
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Antonio, TX 78229, USA
Similar Awards
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...
- This Project Grant award, valued at $399,729.00, was provided by the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project focused on the clinical effectiveness of nonopioid pain management approaches to improve outcomes among active-duty service members. The award was granted to the University of Illinois, which will conduct this research over a 2-year period from November 1,...
- This Project Grant award for $737,998.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program, will fund research by The University of Texas Southwestern Medical Center to target MNK signaling to prevent and reverse chronic pain caused by complex traumatic injury. The research aims to develop innovative therapeutic approaches to address this significant medical challenge affecting military personnel. As a prominent academic...
- The University of Texas Southwestern Medical Center received a $1.46 million Project Grant award from the Department of the Army Medical Command to develop a small chemical drug targeting EphB1 for the treatment of chronic pain. The grant was awarded on September 30, 2021 with a completion date of September 29, 2024. The funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical...
- The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $6,133,100 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 4-year research project to develop and validate personalized treatment models for persistent headaches attributable to mild traumatic brain injury in U.S. military service members and veterans. The research includes specifying and validating patient-centered models...
- Federal Grant Award Summary The University of Texas Health Science Center at San Antonio received a $1.56M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 30, 2025, through September 29, 2029. The award supports a randomized clinical trial designed to reduce aggression in military personnel. As a comprehensive academic medical center with established expertise in serving military and veteran...
- This $366,000 federal Project Grant award, titled "VALIDATION OF A NONOPIOID ANALGESIC PATHWAY IN HUMAN SENSORY GANGLIA AND SPINAL CORD," was issued on September 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award was granted to the University of Florida to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research will explore innovative...
- The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $2.35M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded July 1, 2025, with a completion date of June 30, 2029. This award funds research to evaluate a technology-enhanced, entirely remote two-week integrated treatment protocol that combines neuromodulation with prolonged exposure therapy to address both pain and...
- The University of Texas Health Science Center of San Antonio (UTHSCSA) received a $978,159 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into purinergic receptor antagonist therapeutics for treating metastatic renal cancer from July 1, 2023 through June 30, 2026. As the prime awardee, UTHSCSA will conduct research to develop medical solutions for cancer on the battlefield and...